Literature DB >> 3286676

Bone marrow purging using monoclonal antibodies.

N K Ramsay1, J H Kersey.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3286676     DOI： 10.1007/bf00917894

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.317


× No keyword cloud information.
  44 in total

1.  Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.

Authors:  T Takvorian; G P Canellos; J Ritz; A S Freedman; K C Anderson; P Mauch; N Tarbell; F Coral; H Daley; B Yeap
Journal:  N Engl J Med       Date:  1987-06-11       Impact factor: 91.245

2.  Allogeneic bone marrow transplantation for patients with acute nonlymphocytic leukemia.

Authors:  R Dinsmore; D Kirkpatrick; N Flomenberg; S Gulati; N Kapoor; J Brochstein; B Shank; A Reid; S Groshen; R J O'Reilly
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

3.  In vitro cytodestruction of leukemic cells in human bone marrow using a cocktail of monoclonal antibodies.

Authors:  T W LeBien; R C Ash; E D Zanjani; J H Kersey
Journal:  Haematol Blood Transfus       Date:  1983

4.  A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.

Authors:  C C Soderling; C W Song; B R Blazar; D A Vallera
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

5.  Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement.

Authors:  N Ramsay; T LeBien; M Nesbit; P McGlave; D Weisdorf; P Kenyon; D Hurd; A Goldman; T Kim; J Kersey
Journal:  Blood       Date:  1985-09       Impact factor: 22.113

6.  Monoclonal antibody BA-1 does not bind to hematopoietic precursor cells.

Authors:  J Jansen; R C Ash; E D Zanjani; T W LeBien; J H Kersey
Journal:  Blood       Date:  1982-05       Impact factor: 22.113

7.  Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias.

Authors:  D Maraninchi; E Gluckman; D Blaise; D Guyotat; B Rio; J L Pico; V Leblond; M Michallet; F Dreyfus; N Ifrah
Journal:  Lancet       Date:  1987-07-25       Impact factor: 79.321

8.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia.

Authors:  K D Sabbath; E D Ball; P Larcom; R B Davis; J D Griffin
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

9.  Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors.

Authors:  B Bostrom; R D Brunning; P McGlave; N Ramsay; M Nesbit; W G Woods; D Hurd; W Krivit; T Kim; A Goldman
Journal:  Blood       Date:  1985-05       Impact factor: 22.113

10.  Standardization of monoclonal antibodies for use in autologous bone marrow transplantation for common acute lymphoblastic leukemia.

Authors:  K F Bradstock; E J Favaloro; A Kabral; A Kerr; M Prendergast; M C Berndt; W G Hughes; H Zola; R Krishnan; D Haylock
Journal:  Pathology       Date:  1986-04       Impact factor: 5.306
View more
  1 in total

1.  Receptor-mediated cell attachment and detachment kinetics. I. Probabilistic model and analysis.

Authors:  C Cozens-Roberts; D A Lauffenburger; J A Quinn
Journal:  Biophys J       Date:  1990-10       Impact factor: 4.033
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.